[New guidelines for pulmonary tuberculosis therapy].
D000995:Antitubercular Agents / Q000008:administration & dosage*; D004352:Drug Resistance, Microbial; D004977:Ethambutol / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D007538:Isoniazid / Q000008:administration & dosage / Q000009:adverse effects; D012008:Recurrence; D012293:Rifampin / Q000008:administration & dosage / Q000009:adverse effects; D013307:Streptomycin / Q000008:administration & dosage / Q000009:adverse effects; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*
D000995:Antitubercular Agents; D004977:Ethambutol; D007538:Isoniazid; D012293:Rifampin; D013307:Streptomycin
Neue Richtlinien zur Therapie der Lungentuberkulose.